EssilorLuxottica (OTCMKTS:ESLOY) Rating Increased to Buy at Kepler Capital Markets

EssilorLuxottica (OTCMKTS:ESLOY) was upgraded by investment analysts at Kepler Capital Markets from a “hold” rating to a “buy” rating in a report released on Thursday, Marketbeat reports.

Several other research firms also recently issued reports on ESLOY. HSBC raised EssilorLuxottica from a “hold” rating to a “buy” rating in a report on Wednesday. Citigroup reiterated a “buy” rating on shares of EssilorLuxottica in a research report on Thursday, December 11th. UBS Group raised EssilorLuxottica from a “hold” rating to a “strong-buy” rating in a report on Thursday, November 27th. The Goldman Sachs Group reaffirmed a “buy” rating on shares of EssilorLuxottica in a research note on Friday, December 5th. Finally, Zacks Research cut shares of EssilorLuxottica from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, EssilorLuxottica has a consensus rating of “Buy”.

EssilorLuxottica Stock Performance

Shares of OTCMKTS:ESLOY opened at $163.04 on Thursday. The business has a 50 day moving average price of $169.94 and a 200 day moving average price of $161.63. The company has a debt-to-equity ratio of 0.18, a quick ratio of 0.67 and a current ratio of 0.97. EssilorLuxottica has a twelve month low of $121.51 and a twelve month high of $186.81.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.